These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 2143088)

  • 1. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. III. Proteoglycans.
    Franchimont P; Hazee-Hagelstein MT; Hazout A; Gysen P; Salat-Baroux J; Schatz B; Demerle F
    Biol Reprod; 1990 Aug; 43(2):183-90. PubMed ID: 2143088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of GnRH analogue therapy in IVF in women with unexplained infertility.
    Ashkenazi J; Dicker D; Feldberg D; Goldman GA; Yeshaya A; Goldman JA
    Hum Reprod; 1989 Aug; 4(6):667-9. PubMed ID: 2528570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma and follicular fluid hormone profiles following stimulation with HMG, with or without LHRH agonists, for in-vitro fertilization.
    Firmin C; Antoine JM; Millot F; Alvarez S; Debray M; Tibi C; Cornet D; Salat-Baroux J; Laruelle P
    Hum Reprod; 1991 May; 6(5):653-8. PubMed ID: 1834692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human follicular fluid levels of endothelins in relation to oocyte maturity status.
    Sudik R; Chari S; Pascher E; Sturm G
    Exp Clin Endocrinol Diabetes; 1996; 104(1):78-84. PubMed ID: 8750575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin.
    Humaidan P; Westergaard LG; Mikkelsen AL; Fukuda M; Yding Andersen C
    Fertil Steril; 2011 May; 95(6):2034-8. PubMed ID: 21377153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. II. Inhibin and aromatase inhibitor activity.
    Franchimont P; Hazeé-Hagelstein MT; Charlet-Renard C; Jaspar JM; Hazout A; Salat-Baroux J; Schatz B; Demerlé F
    J Clin Endocrinol Metab; 1990 Sep; 71(3):748-54. PubMed ID: 2118541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive pills and follicular fluid hormones in an in vitro fertilization program.
    Weisman Z; Dirnfeld M; Lissak A; Sorokin Y; Abramovici H
    Fertil Steril; 1989 Sep; 52(3):451-3. PubMed ID: 2506078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. I. Sex steroids.
    Franchimont P; Hazée-Hagelstein MT; Hazout A; Frydman R; Schatz B; Demerlé F
    Fertil Steril; 1989 Dec; 52(6):1006-11. PubMed ID: 2591557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
    Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of hCG administration in cycles stimulated for in vitro fertilization: specific impact of heterogeneous follicle sizes and steroid concentrations in plasma and follicle fluid on decision procedures.
    Inaudi P; Germond M; Senn A; De Grandi P
    Gynecol Endocrinol; 1995 Sep; 9(3):201-8. PubMed ID: 8540289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of oestradiol values in IVF-ET under a combined GnRH analogue--desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies.
    Mettler L; Tavmergen EN
    Hum Reprod; 1989 Nov; 4(8 Suppl):59-64. PubMed ID: 2533218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do analogues of gonadotrophin releasing hormone influence follicular fluid steroid levels, oocyte maturity and fertilization rates?
    Tavmergen E; Tavmergen EN; Capanoğlu R
    Hum Reprod; 1992 Apr; 7(4):479-82. PubMed ID: 1387881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular fluid steroid content and in vitro steroid secretion by granulosa-lutein cells from individual follicles among different stimulation protocols for in vitro fertilization-embryo transfer.
    Hill GA; Osteen KG
    J In Vitro Fert Embryo Transf; 1989 Aug; 6(4):201-6. PubMed ID: 2614215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
    Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
    Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between prolactin, gonadotrophins and steroid hormones in serum and follicular fluid after stimulation with gonadotrophin-releasing hormone agonists and human menopausal gonadotrophin for an in-vitro fertilization programme.
    Kamel MA; Zabel G; Bernart W; Neulen J; Breckwoldt M
    Hum Reprod; 1994 Oct; 9(10):1803-6. PubMed ID: 7844206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.
    Zheng M; Tong J; Li WP; Chen ZJ; Zhang C
    Gynecol Endocrinol; 2018 May; 34(5):446-450. PubMed ID: 29185361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.